ICICI Bank, Paytm, NBCC, Zydus Lifesciences, other stocks in focus today

Stocks to watch: Domestic equity benchmarks Nifty and Sensex are likely to make a negative start to the day and the week amid weak signals from global markets, as investors stare at the risk of a wider conflict in the Middle East and await key macro data and big tech results from the world's largest economy. GIFT Nifty futures were last seen trading 77.5 points, or 0.4 per cent, higher at 19,504 ahead of the opening bell on Dalal Street, having risen as much as 98 points, or 0.5 per cent, to 19,524.5 earlier on Monday.

Here's a list of stocks that are likely to be in the spotlight in the domestic stock market on October 23:

ICICI Bank

The country's second largest private sector lender reported a largely positive set of quarterly numbers over the weekend. Its net profit and net interest income (NII) came in better than analysts' estimates for the quarter ended September but a compression in its net interest margin was worse than expectations. Read more on ICICI Bank results here

RBL Bank

RBL Bank reported a net profit and net interest income for the July-September period that fell slightly short of Street estimates amid an increase in both provisions and slippages. 

Paytm

Paytm's net loss narrowed to Rs 292 crore for the July-September period as against a net loss of 572 crore for the corresponding quarter a year ago, with a 31.6 per cent yearon-year increase in revenue.

IDBI Bank

IDBI Bank registered an overall good September quarter with a 12 per cent year-on-year increase in net interest income and 60 per cent growth in net profit. Read more on IDBI Bank results

Poonawalla Fincorp

Poonawala Fincorp staged a strong quarterly performance with a 73.3 per cent year-on-year jump in net interest income and an 8.6 times surge in net profit. The company's asset quality also improved, with net non-performing assets as a percentage of total loans at 0.72 per cent for the September quarter as against 0.76 per cent for the previous three months. 

October 23 is going to be a relatively less busy day for Dalal Street in terms of earnings announcements. PNB Housing Finance, Torrent Pharma, Mahindra Logistics, Mahindra Holidays & Resorts and NDTV are among the few corporates scheduled to report their quarterly numbers on this day.

NBCC will e-auction commercial space to the tune of 14.8 lakh square feet, worth Rs 5,716 crore, in World Trade Centre, Nauroji Nagar, New Delhi. Zydus Lifesciences has received final approval of the US Food and Drug Administration (FDA) for its ZITUVIOTM drug, used in the treatment of adult patients with Type 2 diabetes.

In a quarterly business update, Oberoi Realty said its bookings dropped 16.5 per cent to Rs 965 crore in the July-September period. Samvardhana Motherson International has announced three acquisitions valued at over Rs 380 crore in aerospace, health and medical sectors, to strengthen its non-automotive businesses. The aerospace division of Samvardhana Motherson International Ltd (SAMIL) is building its capabilities in a phased and strategic manner, enabling it to offer a much wider range of services to aerospace OEMs, according to a company statement.

With inputs from agencies

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.